SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
124.90    5.60 (4.69%)
Bid:
124.50
Ask:
125.00
Spread: 0.50 (0.402%)
Market Cap: £1.39b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Year-end trading update

31 Jan 2023 07:00

RNS Number : 3238O
SigmaRoc PLC
31 January 2023
 

31 January 2023

 

(EPIC: SRC / Market: AIM / Sector: Construction Materials)

 

SIGMAROC PLC

 ('SigmaRoc', the 'Group' or the 'Company')

 

Year-end trading update

 

SigmaRoc (AIM: SRC), the quarried materials group, today provides an update on performance for the year ended 31 December 2022 ('FY22'), ahead of the publication of its final audited results by the end of March 2023.

 

FY22 highlights

Further to the update of 12 December 2022, trading in the final weeks of the year was strong, with the Group expecting to report underlying FY22 EBITDA and EPS slightly ahead of current market consensus expecations1:

 

- Revenues expected to be greater than £525m, including organic like-for-like growth of 19%;

- Underlying EBITDA expected to be greater than £100m, with margins increasing year-on-year to approximately 19%;

- Underlying EPS expected to be greater than 7.7 pence, up over 40% on the prior year;

- Following strong cash generation in the second half, year-end leverage expected to be within the Group's target below 2.0x.

Outlook for FY23

Trading in the early weeks of FY23 has been encouraging, with more favourable energy cost and availability conditions supporting better than expected demand in a number of the Group's European industrial products segments. The Group has continued to take a dynamic position on pricing through inflationary cost increases, as well as identifying opportunities to improve efficiency across its network. As such, the Board remains confident in the Group's ability to achieve further progress in 2023.

 

Throughout 2022 and into 2023, the Group has continued to develop its pipeline of strategic development projects, both organic and inorganic, with opportunities identified to accelerate strategic objectives and enhance financial performance across many of the Group's platforms. The Board continues to develop these initiatives and will update shareholders on progress throughout the year.

 

Max Vermorken, CEO of SigmaRoc, commented:

"Whilst 2022 comprised a long series of operational and commercial challenges, the Group delivered performance well ahead of our original expectations, demonstrating the strength of our operating model and local management teams.

 

2023 has started in an encouraging way and we have identified accretive opportunities that we believe can improve performance and accelerate our strategic goals. We remain mindful that the economic backdrop continues to present uncertainty and challenge in the near term, but we are equally confident that the Group can again demonstrate its resilience and achieve further strategic progress in the year ahead."

 

FY22 annual report and financial statements

The Group intends to publish its audited results for the year ended 31 December 2022 by the end of March 2023, followed by its ESG report in April 2023.

 

Information on the Company is available on its website, www.sigmaroc.com.

 

1Average of Analyst consensus estimates are revenue of £525m, underlying EBITDA of £99.5m, underlying EPS of 7.7p and leverage ratio of 2.0x.

 

 

 

SigmaRoc plc

Max Vermorken / Garth Palmer

 

Tel: +44 (0) 207 002 1080

Liberum Capital (Co-Broker & Nominated Adviser)

Nicholas How / Jamie Richards / Ben Cryer

 

Tel: +44 (0) 203 100 2000

 

 

Peel Hunt (Co-Broker)

Mike Bell / Ed Allsopp

 

Tel: +44 (0) 20 7418 8900

Investor Relations

Dean Masefield / Elisa Frenay

Tel: +44 (0) 207 002 1080

ir@sigmaroc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKBLFXXFLFBBQ
Date   Source Headline
15th Jun 20267:00 amRNSShare Purchase by Director
2nd Jun 202610:27 amRNSTR-1: Notification of Major Holdings
1st Jun 20261:51 pmRNSTR-1: Notification of Major Holdings
30th Apr 20263:37 pmRNSAGM Result
30th Apr 20267:00 amRNSAGM Statement
20th Apr 20267:00 amRNSTR-1: Notification of Major Holdings
9th Apr 20263:21 pmRNSPDMR Dealing
31st Mar 20267:00 amRNSNew debt facility
26th Mar 20267:00 amRNSShare Purchases by Director
19th Mar 20267:00 amRNSShare Purchases by Directors
18th Mar 20269:55 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
3rd Mar 20268:00 amRNS-RSkreenHouse Litherm
3rd Mar 20267:00 amRNSNotice of Results
23rd Feb 20263:59 pmRNSTR-1: Notification of Major Holdings
28th Jan 20263:40 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20267:00 amRNSExercise of options and sale of shares by PDMRs
19th Jan 20267:00 amRNSYear-end trading update
7th Jan 202611:25 amRNSTR-1: Notification of Major Holdings
17th Dec 20255:41 pmRNSTR-1: Notification of Major Holdings
25th Nov 202512:06 pmRNSTR-1: Notification of Major Holdings
21st Oct 20257:00 amRNSQ3 Trading Update
16th Sep 20257:00 amRNSUpdate in relation to the AMeLi project
8th Sep 20257:25 amRNSInterim Results
27th Aug 20257:00 amRNSTR-1: Notification of Major Holdings
12th Aug 20252:57 pmRNSTR-1: Notification of Major Holdings
11th Aug 20251:17 pmRNSTR-1: Notification of Major Holdings
6th Aug 20253:51 pmRNSTR-1: Notification of Major Holdings
24th Jul 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
15th Jul 20257:00 amRNSTR-1: Notification of Major Holdings
11th Jul 20259:45 amRNSHolding(s) in Company
9th Jul 20253:16 pmRNSHolding(s) in Company
3rd Jul 20253:28 pmRNSTR-1: Notification of Major Holdings
10th Jun 20259:15 amRNS-RSeed funding of Koncrete
15th May 202511:48 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSCapital Markets Day
1st May 20254:01 pmRNSAGM Result
1st May 20257:00 amRNSAGM Statement
25th Apr 20257:00 amRNS-RPartnership with Adaptavate
10th Apr 20252:18 pmRNSAwards under SIP to Directors and PDMRs
1st Apr 20257:00 amRNSNotice of AGM and Posting of Annual Report
20th Mar 202510:29 amRNSTR-1: Notification of Major Holdings
17th Mar 20257:01 amRNSCapital Markets Day
17th Mar 20257:00 amRNSFull Year Results
27th Feb 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.